Inicio › Colitis ulcerativa › Massachusetts
Ensayos clínicos de Colitis ulcerativa en Massachusetts
18 estudios sobre Colitis ulcerativa buscan participantes en Massachusetts.
Ciudades en Massachusetts
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07186101Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
- Brigham and Women's Hospital, Boston
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07913347A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
ReclutandoFase 2
Edades de 12 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT05287126A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07012395Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 23 oct 2026 · NCT05987852An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
ReclutandoFase 2/3
Edades de 2 a 17 · Todos los sexos · Actualizado el 20 oct 2026 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07185009A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 7 oct 2026 · NCT04844606Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 14 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT06655415Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 jul 2026 · NCT06420375Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 20 oct 2025 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
ReclutandoEstudio observacional
Edades de 5 a 25 · Todos los sexos · Actualizado el 3 mar 2025 · NCT04331639De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.